Additional Polycyclo Ring System Having At Least Three Cyclos Attached Directly Or Indirectly To The Anthrone Or Anthraquinone By Nonionic Bonding Patents (Class 548/357.1)
Abstract: A water-soluble dye of the Formula (1): D1-L-D2 ??Formula (1) wherein D1 and D2 each independently is an anthrapyridone, anthrapyrazole, anthrapyrimidine or anthrapyrimidone group; and L is a single covalent bond or a linking group which permits at least partial delocalisation of electrons between D1 and D2, compositions and inks containing the dye, and printing processes, printed material and ink-jet printer cartridges based on use of the dye.
Abstract: A water-soluble dye of the Formula (1): D1-L-D2 ??Formula (1) wherein: D1 and D2 each independently is an anthrapyridone, anthrapyrazole, anthrapyrimidine or anthrapyrimidone group; and L is a single covalent bond or a linking group which permits at least partial delocalisation of electrons between D1 and D2. Also, compositions and inks, printing processes, printed material and ink-jet printer cartridges.
Abstract: A novel organic compound and a high-performance organic light-emitting element containing the same. The organic light-emitting element contains a novel compound having a fluoranthene structure.
Abstract: The invention relates to 4-cyanopyrazole-3-carboxamide derivatives of formula (I): in which R1, R2, R3, R4, R5, R6, R7, R8 are as described herein. Also disclosed and claimed are the method of preparation and therapeutic application of compound of formula (I).
Type:
Grant
Filed:
December 22, 2005
Date of Patent:
October 16, 2007
Assignee:
Sanofi-Aventis
Inventors:
Francis Barth, Christian Congy, Serge Martinez, Murielle Rinaldi-Carmona
Abstract: Compounds having activity as selective inhibitors of JNK are disclosed The compounds of this invention are pyrazoloanthrone and derivatives thereof having the following structure: wherein R1 and R2 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.
Type:
Grant
Filed:
August 18, 2000
Date of Patent:
October 10, 2006
Assignee:
Signal Pharmaceuticals, LLC
Inventors:
Brydon L. Bennett, Shripad S. Bhagwat, Anthony M. Manning, Brion W. Murray, Eoin C. O'Leary, Yoshitaka Satoh